Maynard Um
-
-
-
-
-
-
-
Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q2 EPS by 4c
-
-
-
-
-
-
-
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $21 at Mizuho, 'a current top pick'
-
-
-
-
-
-
-
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $28 at H.C. Wainwright
-
-
-
-
-
-
-
Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (AMLX): Grabar Law Office is Investigating Claims on Your Behalf as Securities Fraud Class Action Survives Motion to Dismiss
-
-
-
-
-
-
-
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $25 at Guggenheim
-
-
-
-
-
-
-
Goldman Sachs Resumes Amylyx Pharmaceuticals inc. (AMLX) at Buy
-
-
-
-
-
-
-
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $16 at H.C. Wainwright
-
444,390 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

